These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29520305)

  • 1. Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting.
    Bodero L; López Rivas P; Korsak B; Hechler T; Pahl A; Müller C; Arosio D; Pignataro L; Gennari C; Piarulli U
    Beilstein J Org Chem; 2018; 14():407-415. PubMed ID: 29520305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugates of Cryptophycin and RGD or
    Borbély A; Figueras E; Martins A; Bodero L; Raposo Moreira Dias A; López Rivas P; Pina A; Arosio D; Gallinari P; Frese M; Steinkühler C; Gennari C; Piarulli U; Sewald N
    ChemistryOpen; 2019 Jun; 8(6):737-742. PubMed ID: 31275795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
    Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
    ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic RGD and
    Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Targeting with an isoDGR-Drug Conjugate.
    Zanella S; Angerani S; Pina A; López Rivas P; Giannini C; Panzeri S; Arosio D; Caruso M; Gasparri F; Fraietta I; Albanese C; Marsiglio A; Pignataro L; Belvisi L; Piarulli U; Gennari C
    Chemistry; 2017 Jun; 23(33):7910-7914. PubMed ID: 28449309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α
    Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C
    Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.
    Panzeri S; Zanella S; Arosio D; Vahdati L; Dal Corso A; Pignataro L; Paolillo M; Schinelli S; Belvisi L; Gennari C; Piarulli U
    Chemistry; 2015 Apr; 21(16):6265-71. PubMed ID: 25761230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.
    Colombo R; Mingozzi M; Belvisi L; Arosio D; Piarulli U; Carenini N; Perego P; Zaffaroni N; De Cesare M; Castiglioni V; Scanziani E; Gennari C
    J Med Chem; 2012 Dec; 55(23):10460-74. PubMed ID: 23140358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching.
    Curnis F; Cattaneo A; Longhi R; Sacchi A; Gasparri AM; Pastorino F; Di Matteo P; Traversari C; Bachi A; Ponzoni M; Rizzardi GP; Corti A
    J Biol Chem; 2010 Mar; 285(12):9114-23. PubMed ID: 20064928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to α
    Bernhagen D; De Laporte L; Timmerman P
    Anal Chem; 2017 Jun; 89(11):5991-5997. PubMed ID: 28492301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins.
    Ludwig BS; Tomassi S; Di Maro S; Di Leva FS; Benge A; Reichart F; Nieberler M; Kühn FE; Kessler H; Marinelli L; Reuning U; Kossatz S
    Biomaterials; 2021 Apr; 271():120754. PubMed ID: 33756215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin.
    Burkhart DJ; Kalet BT; Coleman MP; Post GC; Koch TH
    Mol Cancer Ther; 2004 Dec; 3(12):1593-604. PubMed ID: 15634653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the enzymatic release of MMAE from
    Zambra M; Ranđelović I; Talarico F; Borbély A; Svajda L; Tóvári J; Mező G; Bodero L; Colombo S; Arrigoni F; Fasola E; Gazzola S; Piarulli U
    Front Pharmacol; 2023; 14():1215694. PubMed ID: 37492088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α(v)β(3)/α(v)β(5) integrins and IAP proteins.
    Mingozzi M; Manzoni L; Arosio D; Dal Corso A; Manzotti M; Innamorati F; Pignataro L; Lecis D; Delia D; Seneci P; Gennari C
    Org Biomol Chem; 2014 May; 12(20):3288-302. PubMed ID: 24737345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection.
    Veettil MV; Sadagopan S; Sharma-Walia N; Wang FZ; Raghu H; Varga L; Chandran B
    J Virol; 2008 Dec; 82(24):12126-44. PubMed ID: 18829766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.